Outcome of Board Meeting

July 01, 2026 To, To, Listing Department, The National Stock Exchange of India BSE Limited Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai – 400 001 Bandra – Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai – 400051, NSE Scrip Code: AHCL Sub: Outcome of Board Meeting of ANLON HEALTHCARE LIMITED (“Company”) Ref.: Intimation under Regulation 30 of Securities and Exchange Board of India ("SEBI”) (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") – Incorporation of Subsidiaries. Respected Sir/Madam, Pursuant to Regulation 30 read with Part - A of Schedule III of SEBI Listing Regulations, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Wednesday, July 01, 2026 at the Registered Office of the Company inter alia considered and approved the following matters: 1. Pursuant to the provisions of Sections 2(87), 186 and other applicable provisions of the Companies Act, 2013, the Companies (Meetings of Board and its Powers) Rules, 2014, and other applicable provisions of the SEBI Listing Regulations, and all other applicable laws, rules, regulations, guidelines, and circulars issued thereunder, as amended from time to time, the Board of Directors has accorded its consent for incorporation of the following subsidiary companies (“Subsidiary” or "Subsidiaries") of Anlon Healthcare Limited, namely: (i) ANLON MEDICARE PRIVATE LIMITED (ii) ANLON BIOLOGICS PRIVATE LIMITED The relevant details pursuant to Schedule III of the SEBI Listing Regulations and additional details as required under the SEBI Master Circular for compliance with the provisions of the SEBI Listing Regulations by listed entities, bearing ref. no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, as annexed in Annexure - A and Annexure - B. 2. Additionally, the Board of Directors has also provided their approval for changing the name of an existing subsidiary company from “REMEMBER INDIA HEALTH LINKS PRIVATE LIMITED” to “ANLON MEDICOS PRIVATE LIMITED”, subject to approval from Ministry of Corporate affairs (MCA). ANLON HEALTHCARE LIMITED CIN No.: U24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in Meeting Commenced on 10:30 a.m. IST and Concluded on 11:30 a.m. IST. You are requested to take the above information on your record. Thanking You. For ANLON HEALTHCARE LIMITED PUNITKUMAR RASADIA MANAGING DIRECTOR DIN: 06696258 ANLON HEALTHCARE LIMITED CIN No.: U24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in ANNEXURE-A Details required under Regulation 30 of SEBI LODR read with HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Sr Particulars Description 1 Name of the entity, date & country of Name of the Entity: ANLON incorporation, etc. MEDICARE PRIVATE LIMITED (or such other name as may be approved by the relevant authority). The necessary update will be provided to the stock exchange(s) once the Subsidiary is duly incorporated. Date of Incorporation: On receipt of Registrar of Companies approval. Country of Incorporation: India 2 Name of holding company of the Name of Holding Company: Anlon incorporated company and relation with Healthcare Limited the listed entity. The proposed Subsidiary, once incorporated, will be a subsidiary of Anlon Healthcare Limited, the holding company. 3 Industry to which the entity being Pharmaceuticals incorporated belongs. 4 Brief details of any governmental or The incorporation is subject to regulatory approvals required for the receipt of all requisite approvals, incorporation. permissions, and sanctions from the Registrar of Companies, and any other regulatory, statutory, or governmental authority as may be applicable. 5 Consideration - whether cash Subscription to the share capital of consideration or share swap or any other the proposed Subsidiary will be by form and details of the same way of cash consideration. 6 Cost of subscription / the price at which The Company will subscribe to 55% the shares are subscribed. of the equity share capital of the proposed Subsidiary i.e. Company will invest an estimate initial aggregate capital outlay of upto Rs. 1,100,000/- (Rupees Eleven Lakhs Only) to subscribe 1,10,000/- (One Lakh Ten Thousand) equity shares of face value Rs. 10 /- each (Rupees Ten only) of the Subsidiary towards subscription. The Company will subscribe to the Equity Shares at face value. ANLON HEALTHCARE LIMITED CIN No.: U24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in 7 Percentage of shareholding/ control by The Company will hold 55% of the the listed entity and / or number of shares total paid-up equity share capital of allotted. the proposed Subsidiary upon incorporation i.e. Company will invest an estimate initial aggregate capital outlay of upto Rs. 1,100,000/- (Rupees Eleven Lakhs Only) to subscribe 1,10,000/- (One Lakh Ten Thousand) equity shares of face value Rs. 10 /- each (Rupees Ten only) of the Subsidiary towards subscription. 8 Brief background about the entity being This Company is being incorporated incorporated in terms of products / line of for manufacturing surgical implants business and medical devices. In view of the significant growth in this sector in India as well as international markets, we propose to leverage this opportunity in order to strategically complement and expand our existing business in the pain management segment. ANLON HEALTHCARE LIMITED CIN No.: U24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in ANNEXURE - B Details required under Regulation 30 of SEBI LODR read with HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Sr Particulars Description 1 Name of the entity, date & country of Name of the Entity: ANLON incorporation, etc. BIOLOGICS PRIVATE LIMITED (or such other name as may be approved by the relevant authority). The necessary update will be provided to the stock exchange(s) once the Subsidiary is duly incorporated. Date of Incorporation: On receipt of Registrar of Companies approval. Country of Incorporation: India 2 Name of holding company of the Name of Holding Company: Anlon incorporated company and relation with Healthcare Limited the listed entity. The proposed Subsidiary, once incorporated, will be a subsidiary of Anlon Healthcare Limited, the holding company. 3 Industry to which the entity being Pharmaceuticals incorporated belongs. 4 Brief details of any governmental or The incorporation is subject to regulatory approvals required for the receipt of all requisite approvals, incorporation. permissions, and sanctions from the Registrar of Companies, and any other regulatory, statutory, or governmental authority as may be applicable. 5 Consideration - whether cash Subscription to the share capital of consideration or share swap or any other the proposed Subsidiary will be by form and details of the same way of cash consideration. 6 Cost of subscription / the price at which The Company will subscribe to 65% the shares are subscribed. of the equity share capital of the proposed Subsidiary i.e. Company will invest an estimate initial aggregate capital outlay of upto Rs. 650,000/- (Rupees Six Lakhs Fifty Thousand Only) to subscribe 65,000/- (Sixty Five Thousand) equity shares of face value Rs. 10 /- each (Rupees Ten only) of the Subsidiary towards subscription. The Company will subscribe to th [Showing first 8,000 characters — download PDF for full document]